Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC(SYNSTAR01)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 380
- Run by
- CSPC Megalith Biopharmaceutical Co.,Ltd.
See details and how to joinNCT06927986 - 2. fázisTaking peopleHypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 160
- Run by
- Sun Yat-sen University
See details and how to joinNCT07609121 - 4. fázisNot yet taking people in KínaRucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 29
- Run by
- Hunan Cancer Hospital
See details and how to joinNCT07674368 - No phaseTaking peopleDLL3-Targeted PET/CT in Small Cell Lung Cancer
- Where
- Xiamen
- Életkor
- 18 év to 80 év
- People
- 20
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07677787 - No phaseTaking peopleExploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Geneplus-Beijing Co. Ltd.
See details and how to joinNCT05965557 - 1. fázisTaking peopleA Study of DEG6498 in Participants With Solid Tumors
- Where
- Beijing, Guangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Degron Therapeutics Co.
See details and how to joinNCT07244835 - No phaseTaking peopleRGL-270 + ICI in Advanced NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 40
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT07652125 - Korai 1. fázisNot yet taking people in KínaA Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Beijing Geekgene Technology Co., LTD
See details and how to joinNCT07673419 - No phaseNot yet taking people in KínaManagement Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 160
- Run by
- Sun Yat-sen University
See details and how to joinNCT07674524 - 1. fázisTaking peopleSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Where
- Changchun, Shanghai
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00 - 2. fázisNot yet taking people in KínaPhase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 30
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07670715 - 2/3. fázisTaking peopleSFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
- Where
- Nanchang
- Életkor
- 18 év to 85 év
- People
- 30
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07131319 - No phaseTaking peopleCharacterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 600
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07668037 - No phaseTaking peopleElectro-Acupuncture in Lung cancER : EALER Study
- Where
- Guangzhou, Nanjing
- Életkor
- 18 év and over
- People
- 424
- Run by
- Guangzhou University of Traditional Chinese Medicine
See details and how to joinNCT07337096 - 2/3. fázisTaking peopleSCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 410
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT07662395 - No phaseTaking peopleEffectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 316
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07662733 - 1. fázisTaking peopleZorifertinib With Osimertinib for NSCLC With Meningeal Progression
- Where
- Beijing, Guangzhou, Henan, Shanxi, Shengyang
- Életkor
- 18 év and over
- People
- 42
- Run by
- Alpha Biopharma (Jiangsu) Co., Ltd.
See details and how to joinNCT07361705 - 2. fázisNot yet taking people in KínaA Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 154
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT07661173 - 1/2. fázisTaking peopleA Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 260
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07208773 - 1/2. fázisTaking people68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Peking University First Hospital
See details and how to joinNCT07508852 - 1/2. fázisTaking peopleVebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
- Where
- Nanchang
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07655622 - 2. fázisTaking peopleA Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Harbin, Hefei, Jinan, Nanjing, Nanning, Shanghai, Shenyang, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 86
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT07164170 - 1. fázisNot yet taking people in KínaStudy of SNH-118110 in Advanced Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 240
- Run by
- ScinnoHub Pharmaceutical Co., Ltd.
See details and how to joinNCT07649200 - 3. fázisTaking peoplePivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer
- Where
- Hangzhou, Shanghai
- Életkor
- 18 év to 75 év
- People
- 440
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07416994 - No phaseNot yet taking people in KínaDeep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 4750
- Run by
- Peking University People's Hospital
See details and how to joinNCT07647692